← Leaderboards
Pei Wang
Fred Hutchinson Cancer Research Center
$7,634,998
Attributed
$14,524,621
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,385,152 · 6
By mechanism
U24$8,351,818 · 2
R01$6,172,803 · 3
U2C$2,860,531 · 1
Top collaborators
- Amanda G Paulovich8 shared
- Avi Ma'Ayan5 shared
- Eric E Schadt5 shared
- Laurel A Habel4 shared
- Weiva Sieh4 shared
- Andrew N Hoofnagle3 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Amanda G Paulovich$38,180,578
- Cornelia M Ulrich$28,998,049
- Sarah Talarico$500,500
- Noel Weiss$6,022,649
- Jennifer A. Doherty$9,064,784
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeGenomicsComplexGenesMalignant NeoplasmsPathway InteractionsMolecularMalignant Breast NeoplasmMiningResourcesData SetBaseProteinsBiologicalProgramsComputerized ToolsTumorLearningInvestigationProteomicsGene ExpressionGeneticNetwork-BasedPattern
Grant awards (27)
Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment$1,056,723
U2C · FY2025 · CA
Proteogenomic translator for cancer biomarker discovery towards precision medicine$821,000
U24 · FY2025 · CA · contact PI
Proteogenomic translator for cancer biomarker discovery towards precision medicine$423,960
U24 · FY2025 · CA · contact PI
Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment$1,011,318
U2C · FY2024 · CA
Proteogenomic translator for cancer biomarker discovery towards precision medicine$787,902
U24 · FY2024 · CA · contact PI
Proteogenomic translator for cancer biomarker discovery towards precision medicine$824,077
U24 · FY2023 · CA · contact PI
Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment$792,490
U2C · FY2023 · CA
Genomic and Transcriptomic Analysis of Mammographic Density$495,945
R01 · FY2023 · CA
Proteogenomic translator for cancer biomarker discovery towards precision medicine$850,957
U24 · FY2022 · CA · contact PI
Genomic and Transcriptomic Analysis of Mammographic Density$474,559
R01 · FY2022 · CA
Genomic and Transcriptomic Analysis of Mammographic Density$484,243
R01 · FY2021 · CA
Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine$907,614
U24 · FY2020 · CA · contact PI
Genomic and Transcriptomic Analysis of Mammographic Density$501,617
R01 · FY2020 · CA
Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine$880,383
U24 · FY2019 · CA · contact PI
Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine$992,364
U24 · FY2018 · CA · contact PI
Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine$919,494
U24 · FY2017 · CA · contact PI
Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine$944,067
U24 · FY2016 · CA · contact PI
Cross-species network approach to predict epistatic cancer susceptibility genes$535,355
R01 · FY2012 · CA
Statistical Methods for Integrative Analysis of Genomics and Proteomics Data$270,511
R01 · FY2012 · GM · contact PI
Cross-species network approach to predict epistatic cancer susceptibility genes$551,809
R01 · FY2011 · CA
Statistical Methods for Integrative Analysis of Genomics and Proteomics Data$270,725
R01 · FY2011 · GM · contact PI
Cross-species network approach to predict epistatic cancer susceptibility genes$586,147
R01 · FY2010 · CA
Statistical Methods for Integrative Analysis of Genomics and Proteomics Data$273,085
R01 · FY2010 · GM · contact PI
Cross-species network approach to predict epistatic cancer susceptibility genes$579,999
R01 · FY2009 · CA
Statistical Methods for Integrative Analysis of Genomics and Proteomics Data$283,189
R01 · FY2009 · GM · contact PI
Cross-species network approach to predict epistatic cancer susceptibility genes$565,632
R01 · FY2008 · CA
Statistical Methods for Integrative Analysis of Genomics and Proteomics Data$299,987
R01 · FY2008 · GM · contact PI